These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

729 related articles for article (PubMed ID: 33785249)

  • 101. Antidiabetic Drugs and their Potential Use in COVID-19: A Mechanistic Approach.
    Espinosa-Rodriguez BA; Nieto-Moreno AM; Gonzalez Llerena JL; Rico-Torres TA; Carranza-Rosales P; Mendez-Lopez LF; Balderas-Renteria I
    Endocr Metab Immune Disord Drug Targets; 2023; 23(3):255-272. PubMed ID: 35578871
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Metformin suppresses SARS-CoV-2 in cell culture.
    Parthasarathy H; Tandel D; Siddiqui AH; Harshan KH
    Virus Res; 2023 Jan; 323():199010. PubMed ID: 36417940
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection.
    Montefusco L; Ben Nasr M; D'Addio F; Loretelli C; Rossi A; Pastore I; Daniele G; Abdelsalam A; Maestroni A; Dell'Acqua M; Ippolito E; Assi E; Usuelli V; Seelam AJ; Fiorina RM; Chebat E; Morpurgo P; Lunati ME; Bolla AM; Finzi G; Abdi R; Bonventre JV; Rusconi S; Riva A; Corradi D; Santus P; Nebuloni M; Folli F; Zuccotti GV; Galli M; Fiorina P
    Nat Metab; 2021 Jun; 3(6):774-785. PubMed ID: 34035524
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Current management of diabetes patients with COVID-19.
    Misra AK; Rangari G; C M; Sharma S
    Expert Rev Endocrinol Metab; 2023 Mar; 18(2):199-207. PubMed ID: 36882971
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Protection by metformin against severe Covid-19: An in-depth mechanistic analysis.
    Wiernsperger N; Al-Salameh A; Cariou B; Lalau JD
    Diabetes Metab; 2022 Jul; 48(4):101359. PubMed ID: 35662580
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients' susceptibility to COVID-19 to the possible caution of future global diabetes tsunami.
    Sharbatdar Y; Mousavian R; Noorbakhsh Varnosfaderani SM; Aziziyan F; Liaghat M; Baziyar P; Yousefi Rad A; Tavakol C; Moeini AM; Nabi-Afjadi M; Zalpoor H; Kazemi-Lomedasht F
    Inflammopharmacology; 2023 Jun; 31(3):1029-1052. PubMed ID: 37079169
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Diabetes and SARS-CoV-2 Infection: The Potential Role of Antidiabetic Therapy in the Evolution of COVID-19.
    Pinchera B; Schiano Moriello N; Buonomo AR; Di Filippo I; Tanzillo A; Buzzo G; Villari R; Gentile I; Federico Ii Covid Team
    Microorganisms; 2023 Jan; 11(1):. PubMed ID: 36677437
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Insulin therapy in patients with COVID-19.
    Kow CS; Ramachandram DS; Hasan SS
    Acta Diabetol; 2022 Feb; 59(2):285-286. PubMed ID: 34648089
    [No Abstract]   [Full Text] [Related]  

  • 109. Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications.
    Santos A; Magro DO; Evangelista-Poderoso R; Saad MJA
    Diabetol Metab Syndr; 2021 Mar; 13(1):23. PubMed ID: 33648564
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Current management of diabetes patients with COVID-19.
    Misra AK; Rangari G; C M; Sharma S
    Expert Rev Endocrinol Metab; 2023 Mar; ():1-9. PubMed ID: 36890686
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Inpatient Use of Metformin and Acarbose Is Associated with Reduced Mortality of COVID-19 Patients with Type 2 Diabetes Mellitus.
    Li W; Li J; Wei Q; McCowen K; Xiong W; Liu J; Jiang W; Thomas R; Hepokoski M; He M; Shyy J; Malhotra A; Xiong N
    Res Sq; 2021 Mar; ():. PubMed ID: 33791691
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England.
    Khunti K; Knighton P; Zaccardi F; Bakhai C; Barron E; Holman N; Kar P; Meace C; Sattar N; Sharp S; Wareham NJ; Weaver A; Woch E; Young B; Valabhji J
    Lancet Diabetes Endocrinol; 2021 May; 9(5):293-303. PubMed ID: 33798464
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Metformin: The next angiogenesis panacea?
    Ren Y; Luo H
    SAGE Open Med; 2021; 9():20503121211001641. PubMed ID: 33796300
    [TBL] [Abstract][Full Text] [Related]  

  • 114. The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review.
    Zangiabadian M; Nejadghaderi SA; Zahmatkesh MM; Hajikhani B; Mirsaeidi M; Nasiri MJ
    Front Endocrinol (Lausanne); 2021; 12():645194. PubMed ID: 33815295
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Metformin: Is It the Well Wisher of Bone Beyond Glycemic Control in Diabetes Mellitus?
    Shaik AR; Singh P; Shaik C; Kohli S; Vohora D; Ferrari SL
    Calcif Tissue Int; 2021 Jun; 108(6):693-707. PubMed ID: 33797562
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Multifaceted Mechanisms of Action of Metformin Which Have Been Unraveled One after Another in the Long History.
    Kaneto H; Kimura T; Obata A; Shimoda M; Kaku K
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807522
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Concerted outcome of metformin and low dose of radiation in modulation of cisplatin induced uremic encephalopathy via renal and neural preservation.
    Hasan HF; Rashed LA; El Bakary NM
    Life Sci; 2021 Jul; 276():119429. PubMed ID: 33785333
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Associations between dysbiosis-inducing drugs, overall survival and tumor response in patients treated with immune checkpoint inhibitors.
    Gaucher L; Adda L; Séjourné A; Joachim C; Guillaume C; Poulet C; Liabeuf S; Gras-Champel V; Masmoudi K; Houessinon A; Bennis Y; Batteux B
    Ther Adv Med Oncol; 2021; 13():17588359211000591. PubMed ID: 33796151
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Management of patients with type 2 diabetes and cardiovascular disease in primary care.
    Marson A; Raffoul N; Osman R; Deed G
    Aust J Gen Pract; 2021 Apr; 50(4):238-245. PubMed ID: 33786549
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Bromodomain protein BRD4 is an epigenetic activator of B7-H6 expression in acute myeloid leukemia.
    Baragaño Raneros A; Rodriguez RM; Bernardo Flórez A; Palomo P; Colado E; Minguela A; Suárez Álvarez B; López-Larrea C
    Oncoimmunology; 2021 Mar; 10(1):1897294. PubMed ID: 33796404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.